6th Jun 2007 11:48
Advanced Medical Solutions Grp PLC06 June 2007 For immediate release 6 June 2007 Advanced Medical Solutions Group plc ("AMS" or "the Company") Annual General Meeting Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today held its Annual General Meeting at which allof the resolutions put to shareholders were duly passed. These resolutions included a special resolution which approved the reduction ofthe Company's share capital by the cancellation of its deferred shares and thecancellation of the Company's share premium account. Further to theannouncement of 27 April 2007, the Company will now seek the confirmation of theproposed reduction and cancellation by the High Court of Justice. It iscurrently anticipated that the court will hear the Company's application on 4July 2007 and that the proposed reduction and cancellation, if confirmed by thecourt at that hearing, will become effective shortly thereafter upon theregistration by the Registrar of Companies of the court order and of the minuteapproved by the court setting out the particulars of the Company's share capitalas altered by that order. Don Evans, AMS' Chief Executive, gave a presentation at today's AGM, a copy ofwhich will be available on the Company's website, www.admedsol.com, later today. -- ENDS -- For further information, please contact: Advanced Medical Solutions Group plc +44 (0) 01606 545508Don Evans (Chief Executive Officer)Mary Tavener (Group Finance Director)www.admedsol.com Buchanan Communications +44 (0) 020 7466 5000Mark Court/Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a UK based company developing and providingleading edge technology to the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, the Company is focused on the design,development, manufacture and sale of advanced woundcare dressings and productsfor closing wounds and sealing tissue. AMS provides a full range of advanced woundcare products for sale in hospital,nursing home and community care markets. The main indications are for chronicwounds such as ulcers and pressure sores. These products pioneer the concept ofmoist wound healing to allow wounds to heal faster and with less pain andscarring if they remain moist. They protect the wound, deal with tissue fluidsand provide an optimal environment for healing to occur. AMS' resources ensurea unique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products based uponcyanoacrylate adhesive technology which allow the closure of wounds followingtrauma or surgical incisions, or seal skin to protect against breakdown or woundinfection. These products address the emerging tissue adhesives and sealantssegment of the wound closure market. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group